Advertisement

Picture Berlin Partner Hotspot for Startups 650x80px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements in France and Monaco or involving organisations from these countries.

Total search results: 1248 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Mobidiag–Hologic: investment, 202104– acquisition €600m in cash ANNOUNCED 2021-04-08
Pyxis Oncology–SEVERAL: investment, 202103 financing round Series B $152m led by Arix Bioscience 2021-03-30
Step Pharma–France (govt): investment, 202103 financing round Series B totalling €35m incl existing + co-investor Bpifrance via IBRD + InnoBio 2 funds 2021-03-24
Step Pharma–Hadean Ventures: investment, 202103 financing round Series B totalling €35m incl new + co-lead investor Hadean Ventures 2021-03-24
Step Pharma–Kurma: investment, 202103 financing round Series B totalling €35m incl existing + co-investor Kurma Partners 2021-03-24
Step Pharma–Pontifax: investment, 202103 financing round Series B totalling €35m incl existing + co-investor Pontifax 2021-03-24
Step Pharma–SEVERAL: investment, 202103 financing round Series B €35m co-led by new investors Hadean Ventures + Sunstone Life Science Ventures 2021-03-24
Step Pharma–Sunstone Life Science: investment, 202103 financing round Series B totalling €35m incl new + co-lead investor Sunstone Life Science 2021-03-24
AgomAb Therapeutics–Andera Partners: investment, 202103 financing round Series B totalling $74m incl existing + co-investor Amdera Partners 2021-03-10
AgomAb Therapeutics–Omnes Capital: investment, 202103 financing round Series B totalling $74m incl existing + co-investor Omnes Capital 2021-03-10
AgomAb Therapeutics–SEVERAL: investment, 202103 financing round Series B $74m led by new investor Redmile Group 2021-03-10
Biolojic Design–Burns McClellan: public relations, 202103 service existent Burns McClellan is media contact 2021-03-08
CVasThera–SEVERAL: investment, 202103 1st financing round €1.3m led by Ocseed 2021-03-03
EG 427–ATCG Partners: public relations, 202103 service existent ATCG is EU media contact 2021-03-01
EG 427–Burns McClellan: public relations, 202103 service existent Burns McClellan is US media contact 2021-03-01
EG 427–PERSON: investment, 202103 financing round series A totalling €12m incl lead investor David Lamon with San Francisco based large family offices 2021-03-01
EG 427–SEVERAL: investment, 202103 financing round series A €12m led by David Lamon with San Francisco based large family offices 2021-03-01
French Myopathy Association–WhiteLab Genomics: genomic s/w tools, 202102– collab Généthon using Catalyst s/w to develop vectors for gene therapies 2021-02-10
CorWave–Taddeo: public relations, 202102 supply service existent by Taddeo 2021-02-08
Enthera–Roche: investment, 202101 financing round Series A extension to final closing at €35m with new investor Roche Venture Fund 2021-01-28
Servier–MiNA Therapeutics: saRNA therapeutics, 202101– collab research + license option for saRNA therapeutics for neurological diaseses 2021-01-21
IO Biotech–Kurma: investment, 202101 financing round Series B totalling €127m incl new + co-investor Kurma Partners 2021-01-13
IO Biotech–SEVERAL: investment, 202101 financing round Series B €127m led by new investor HBM Healthcare Investments 2021-01-13
Sanofi–Biond Biologics: antibody cancer drug, 202101– license ww excl to BND-22 anti-IgG4 antibody $125m upfront + >$1b milestones + royalties 2021-01-12
Kymab–Sanofi: investment, 202101 acquisition $1.1b upfront + $350m milestones ANNOUNCED 2021-01-11
Cellectis–Sirion Biotech: cell/gene therapy manufacturing technology, 202101– non-excl license €na to LentiBoost technology for CAR-T cell therapies 2021-01-07
CorWave–BPCE: investment, 202101 financing round Series C totalling €35m incl existing + co-investor Seventure 2021-01-06
CorWave–EU (govt): investment, 202101 financing round Series C totalling €35m incl €15m from new investor EIC Fund 2021-01-06
CorWave–Financière Arbevel: investment, 202101 financing round Series C totalling €35m incl new + co-investor Financière Arbevel 2021-01-06
CorWave–France (govt): investment, 202101 financing round Series C totalling €35m incl existing + co-investor Bpifrance 2021-01-06
CorWave–M&L Healthcare: investment, 202101 financing round Series C totalling €35m incl new + co-investor M&L Healthcare 2021-01-06
CorWave–Novo Group: investment, 202101 financing round Series C totalling €35m incl existing + co-investor Novo Holdings 2021-01-06
CorWave–SEVERAL: investment, 202101 financing round Series C €35m led by new investor EIC Fund 2021-01-06
CorWave–Sofinnova: investment, 202101 financing round Series C totalling €35m incl existing + co-investor Sofinnova Partners 2021-01-06
CorWave–Ysios Capital: investment, 202101 financing round Series C totalling €35m incl existing + co-investor Ysios Capital 2021-01-06
Volta Medical–Gilde Investment: investment, 202101 financing round totalling $28m incl lead investor Gilde Healthcare 2021-01-05
Volta Medical–SEVERAL: investment, 202101 financing round $28m led by Gilde Healthcare 2021-01-05
Cellectis–SEVERAL: investment, 202012 underwritten public offering of ADSs $100m+15m ANNOUNCED + WITHDRAWN 2020-12-14
InnoSkel–Consilium: public relations, 202012 service existent by Consilium Strategic Communications 2020-12-14
InnoSkel–Jeito Capital: investment, 202012 financing round Series A totalling €20m incl co-lead investor Jeito Capital 2020-12-14
InnoSkel–Région Sud (FR): investment, 202012 financing round Series A totalling €20m incl co-investor Région Sud Investissement 2020-12-14
InnoSkel–SEVERAL: investment, 202012 financing round Series A €20m co-led by Jeito Capital + Vida Ventures 2020-12-14
InnoSkel–Turenne: investment, 202012 financing round Series A totalling €20m incl co-investor The Turenne Group 2020-12-14
InnoSkel–Vida Ventures: investment, 202012 financing round Series A totalling €20m incl co-lead investor Vida Ventures 2020-12-14
MaaT Pharma–Céleste Management: investment, 202012 financing round Series B extension totalling €7.35m incl new + co-investor Céleste Management 2020-12-01
MaaT Pharma–France (govt): investment, 202012 financing round Series B extension totalling €7.35m incl new + lead investor PSIM Fund 2020-12-01
MaaT Pharma–SEVERAL: investment, 202012 financing round Series B extension €7.35m led by Bpifrance bringing total Series B to €25.35m 2020-12-01
MaaT Pharma–SkyViews Life Science: investment, 202012 financing round Series B extension totalling €7.35m incl new + co-investor SkyViews Life Science 2020-12-01
Noema Pharma–SEVERAL: investment, 202012 financing round Series A CHF54m ($59m) co-led by Sofinnova Partners + Polaris Partners 2020-12-01
Slack Technologies–Salesforce: investment, 202012– acquisition $27.7b in cash + shares of Slack by Salesforce ANNOUNCED 2020-12-01
Emergence Therapeutics–High-Tech Gründerfonds: investment, 202011 follow-on seed financing round incl lead investor HTGF 2020-11-25
Emergence Therapeutics–SEVERAL: investment, 202011 follow-on seed financing round led by HTGF 2020-11-25
AlgoTherapeutix–SEVERAL: investment, 202011 financing round Series A €12m led by Bpifrance InnoBio 2 fund + co-investor Omnes 2020-11-24
Catamaran Bio–SEVERAL: investment, 202011 financing round Series A $42m co-led by Sofinnova Partners + Lightstone Ventures 2020-11-23
Catamaran Bio–Sofinnova: investment, 202011 financing round Series A $42m incl co-lead investor Sofinnova Partners 2020-11-23
Voluntis–Debiopharm: investment, 202011 capital increase totalling €5.93m incl €3.92m from new + lead investor Debiopharm Innovation Fund 2020-11-23
Voluntis–Indigo (Eric Carreel): investment, 202011 capital increase totalling €5.93m incl €1m from existing + co-investor Indigo 2020-11-23
Voluntis–SEVERAL: investment, 202011 capital increase €5.93m net €5.7m led by Debiopharm Innovation Fund 2020-11-23
Myricx Pharma–SEVERAL: investment, 202011 seed financing round £4.5m with Sofinnova Partners + Brandon Capital Partners 2020-11-16
Myricx Pharma–Sofinnova: investment, 202011 seed financing round totalling £4.5m incl investor Sofinnova Partners 2020-11-16
Jeito Capital–Sanofi: investment, 202011 investment €50m by Sanofi 2020-11-13
Synendos Therapeutics–SEVERAL: investment, 202011 financing round Series A CHF20m co-led by Kurma Partners + Sunstone LSV 2020-11-12
The Protein Brewery–SEVERAL: investment, 202011 financing round Series A €22m led by Novo Holdings 2020-11-03
Corlieve Therapeutics–SEVERAL: investment, 202011 seed financing round from Kurma Partners + Idinvest Partners + Pureos Bioventures 2020-11-02
Eurofins–Waters: mass spectrometer, 202011 supply existent Radian ASAP System beta customer Eurofins Forenscis Teddington 2020-11-02
Kiadis–Sanofi: investment, 202011– cash tender offer €308m for Kiadis Pharma NV at €5.45 per share (272% premium over closing price on 30 Oct) 2020-11-02
GenSight Biologics–Arix Bioscience: investment, 202010 private placement totalling €25m incl co-lead investor Arix Bioscience 2020-10-22
GenSight Biologics–France (govt): investment, 202010 private placement totalling €25m incl €1m from existing + co-investor Bpifrance Investissement 2020-10-22
GenSight Biologics–Invus Group: investment, 202010 private placement totalling €25m incl co-lead investor Invus 2020-10-22
GenSight Biologics–SEVERAL: investment, 202010 private placement €25m led by Arix Bioscience + Invus + Sofinnova Partners 2020-10-22
GenSight Biologics–Sofinnova: investment, 202010 private placement totalling €25m incl €4.5m from existing + co-lead investor Sofinnova Partners 2020-10-22
SparingVision–4BIO Ventures: investment, 202010 financing round totalling €44.5m incl new + co-lead investor 4BIO Capital 2020-10-21
SparingVision–Consilium: public relations, 202011 service existent by Consilium Strategic Communications 2020-10-21
SparingVision–Foundation Fighting Blindness: investment, 202010 financing round totalling €44.5m incl existing + co-investor FFB 2020-10-21
SparingVision–France (govt): investment, 202010 financing round totalling €44.5m incl existing + co-investor Bpifrance 2020-10-21
SparingVision–Jeito Capital: investment, 202010 financing round totalling €44.5m incl new + co-investor Jeito Capital 2020-10-21
SparingVision–SEVERAL: investment, 202010 financing round €44.5m led by 4BIO Capital + UPMC Enterprises 2020-10-21
SparingVision–Torreya: financial services, 202010 supply service Torreya Capital LLC acted as excl placement agent for €44.5m offering 2020-10-21
SparingVision–Univ Pittsburgh: investment, 202010 financing round totalling €44.5m incl new + co-lead investor UPMC Enterprises 2020-10-21
SparingVision–Ysios Capital: investment, 202010 financing round totalling €44.5m incl new + co-investor Ysios Capital 2020-10-21
VectivBio–SEVERAL: investment, 202010 crossover financing $110m from existing + new investors 2020-10-15
Carmat–France (govt): grant, 202010– grant €13m national innovation funding for clinical study of artificial heart in France from Health Ministry 2020-10-12
Priothera–Earlybird: investment, 202010 financing round Series A totalling €30m incl co-investor Earlybird Venture Capital 2020-10-12
Priothera–Fountain Healthcare Partners: investment, 202010 financing round Series A totalling €30m incl lead investor FHP 2020-10-12
Priothera–Huntsworth: public relations, 202010 service existent by Citigate Dewe Rogerson 2020-10-12
Priothera–Kyorin: mocravimod, 202010c acquisition of mocravimod from Kyorin Pharmaceutical Co Ltd 2020-10-12
Priothera–Odlander Fredrikson: investment, 202010 financing round Series A totalling €30m incl co-lead investor HealthCap 2020-10-12
Priothera–SEVERAL: investment, 202010 financing round Series A €30m led by Fountain Healthcare Partners 2020-10-12
Priothera–Tekla Capital: investment, 202010 financing round Series A totalling €30m incl co-investor funds managed by Tekla Capital Management LLC 2020-10-12
Federation Bio–BPCE: investment, 202010 financing round Series A totalling $50m incl new + co-investor Seventure Partners/Health for Life Capital 2020-10-06
Federation Bio–SEVERAL: investment, 202010 financing round Series A $50m led by Horizons Ventures + incl Seventure Partners + Venrock + Altitude 2020-10-06
Novartis–Merck (DE): Nanobodies, 202010– license €50m upfront + €400m milestones to M6495 anti-ADAMTS5 Nanobody for osteoarthritis 2020-10-06
Ynsect–SEVERAL: investment, 202010 financing round Series C extension to total of $372m led by Astanor Ventures 2020-10-06
BIA Separations–Sartorius: investment, 202010– acquisition €240m in cash + €120m in SSB shares BIA to be merged into SSB ANNOUNCED 2020-10-02
Sophia Genetics–Eurazeo: investment, 202010 financing round Series F totalling $110m incl existing + co-investor Eurazeo Growth 2020-10-01
Kurma–SEVERAL: investment, 202009 first closing €50m of Kurma Diagnostics 2 Fund (KDx2) 2020-09-29
Galecto–SEVERAL: investment, 202009 financing round $64m led by Soleus + co-lead by Eir Ventures 2020-09-25
Bellevue–SEVERAL: investment, 202009 Closing $170m of BB Pureos Bioventures LP fund 2020-09-23
Lava Therapeutics–Sanofi: investment, 202009 financing round Series C totalling $83m incl new + co-lead investor Sanofi Ventures 2020-09-17
ImCheck Therapeutics–Bellevue: investment, 202009 financing round Series B extension €6m from BB Pureos Bioventures bringing total Series B to €54m 2020-09-15
1 2 3 4 5 6 7 8 9 10 11 12 13  next pagenext page



Advertisement

Picture EBD Group Connector Personal Networking in Life Sciences 650x80

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture EBD Group ChinaBio Partnerting Forum 2021 651x80

» top